Apotex Hit With $442 Million Judgment in Bloof Thinner Plavix Patent Suit

By Jack Simony

A Manhattan federal district court judge ordered Apotex to pay $442,209,362 in damages, plus interest in a patent infringement case that was first filed in 2002 by Sanofi-Aventis and Bristol-Myers Squibb, The American Lawyer reported.

Blood thinner Plavix is the world's second-biggest selling drug. According to Bloomberg, the infringement sales took place in August 2006 for a three-week period.

- By Jack Simony